🌍 1 in 4 people globally are South Asian, yet only 3.2% are represented in major #CVD trials. Greater inclusion is crucial in addressing this high-risk population. ❤️🩹 https://t.co/rKwBDuOryR
#JACCAsia #HealthEquity #ClinicalTrials @pnatarajanmd @NishantUppal7 @DLBHATTMD
1
4
19
Replies
Compared with targeting <140 mm Hg, targeting <120 mm Hg halved the risk of hemorrhagic #stroke and did not increase that of ischemic stroke. The stroke-preventing effect emerged after 1 year of intervention. Future studies are needed https://t.co/qB7ZmR2klb
#JACC
1
39
139